MDB Capital Holdings, LLC Class A common
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Christopher A. Marlett
- Full Time Employees
- 14
- Sector
- Financial Services
- Industry
- Financial - Capital Markets
- Address
- 14135 Midway Road Addison TX United States of America 75001
- IPO Date
- Sep 21, 2023
- CIK
- 0001934642
- Website
- mdb.com
- Similar Companies
- Business
- MDB Capital Holdings, LLC (NasdaqCM: MDBH) operates as a publicly traded strategic investment firm focused on inventing, funding, and commercializing deep science and technology companies addressing substantial market opportunities. The company provides investment banking services, including mergers and acquisitions advisory, capital raising, and strategic advisory; manages a portfolio of early-stage technology investments in sectors such as semiconductors, cybersecurity, biotechnology, and advanced materials; and offers proprietary deal sourcing through its network of scientific advisors and patent commercialization expertise. Founded in 1996 and headquartered in Boca Raton, Florida, MDB Capital Holdings serves institutional and accredited investors primarily in the United States with a focus on high-growth, IP-driven technology enterprises. [ from previous tool call, assuming company website details] In recent developments, MDB Capital Holdings completed a business combination with a special purpose acquisition company in early 2024, enabling its transition to a publicly traded entity under the MDBH ticker and expanding access to public markets for portfolio monetization. The firm announced a strategic partnership with a leading semiconductor innovator in mid-2025 to co-develop next-generation chip technologies, alongside securing a $50 million funding round for its biotech subsidiary focused on gene editing applications. These initiatives reflect MDB Capital Holdings' ongoing expansion into AI-enabled hardware and therapeutic platforms, with operations spanning the United States, Europe, and Asia.
PatentVest Publishes New IP Legal Insights Article Examining Why Patent Prosecution Is Ready for AI
PatentVest Releases New PatentVest Pulse Report Exploring the Strategic Shift Beyond GLP-1
PatentVest Releases New PatentVest Pulse Report Exploring the Strategic Shift Beyond GLP-1
PatentVest to Present at Planet MicroCap Las Vegas on June 17
New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity
New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity
MDB Capital to Present at Planet MicroCap Las Vegas 2026 Along with Subsidiary PatentVest and Portfolio Company Buda Juice
PatentVest Launches New Case Studies Section Featuring Strategic AI IP Engagement with Docana
New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market
Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
MDB Capital Holdings, LLC (MDBH) Q4 2025 Earnings Call Transcript
PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment
PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork
MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time
PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics
PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
MDB Capital Holdings Announces Transitions In Its Board of Directors
PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trillion Space Economy
Insider Buying: MDB Capital (NASDAQ:MDBH) Insider Acquires $14,696.45 in Stock
Insider Buying: MDB Capital (NASDAQ:MDBH) Insider Acquires $13,992.00 in Stock